My patient turns 12 years old next week and has never had a COVID-19 vaccination. What options are available?

This child should receive the dose recommended for his age at the time of the vaccination visit. At age 11 years, an age-appropriate single dose of either Pfizer-BioNTech or Moderna mRNA vaccine is recommended. If the patient arrives in your clinic after turning 12 years old, the 2024–2025 Formula Novavax protein subunit vaccine is also an option. If using the Novavax product, a previously unvaccinated person requires two doses, given 3 to 8 weeks apart, as a primary series.